A 1-m distance is not safe for children with cystic fibrosis at risk for cross-infection with Pseudomonas aeruginosa

American Journal of Infection Control

Volumn 38, Issue 3, 2010, Pages 244-245

  Festini, Filippo ^a   Taccetti, Giovanni ^b   Galici, Valeria ^a   Neri, Stella ^a   Bisogni, Sofia ^a   Ciofi, Daniele ^a   Braggion, Cesare ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

cross infection; Cystic fibrosis; infection control; nursing; Pseudomonas aeruginosa

Indexed keywords

ARTICLE; BACTERIAL TRANSMISSION; BACTERIUM CULTURE; CHILD; CHILD SAFETY; CLINICAL ARTICLE; COUGHING; CROSS INFECTION; CYSTIC FIBROSIS; FEMALE; HIGH RISK PATIENT; HUMAN; INFECTION RISK; MALE; PRESCHOOL CHILD; PROBABILITY; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RESPIRATORY TRACT INFECTION; SCHOOL CHILD;

ADOLESCENT; ADULT; CROSS INFECTION; CYSTIC FIBROSIS; FEMALE; HUMANS; INFECTION CONTROL; MALE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RISK ASSESSMENT; YOUNG ADULT;

EID: 77949915258     PISSN: 01966553     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajic.2009.09.017     Document Type: Article

References (10)

1. Saiman L., and Siegel J. Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission. Am J Infect Control 31 (2003) S1-62
2. Cystic Fibrosis Trust. Pseudomonas aeruginosa infection in people with CF: suggestions for prevention and infection control. The Trust (2001) Bromley
3. Cystic Fibrosis Trust. A statement on Burkholderia cepacia. The Trust (1999) Bromley
4. Branger B., Ravilly S., and Houzard S. Association Francaise Lutte contre la Mucoviscidose. Recommandations pour la prevention de l'acquisition et de la transmission des germes respiratoires dans la mucoviscidose. The Association (2004) Paris
5. Doring G., and Hoiby N. Early intervention and prevention of lung disease in cystic fibrosis: a European consensus. J Cyst Fibros 3 (2004) 67-91
6. AARC clinical practice guideline: direct cough. Respir Care 38 (1993) 495-499
7. Spilker T., Coenye T., Vandamme P., and LiPuma J.J. PCR-based assay for differentiation of Pseudomonas aeruginosa from other Pseudomonas species recovered from cystic fibrosis patients. J Clin Microbiol 42 (2004) 2074-2079
8. Zimakoff J., Hoiby N., Rosendal K., and Guilbert J.P. Epidemiology of Pseudomonas aeruginosa infection and the role of contamination of the environment in a cystic fibrosis clinic. J Hosp Infect 4 (1983) 31-40
9. Doring G., Jansen S., Noll H., et al. Distribution and transmission of Pseudomonas aeruginosa and Burkholderia cepacia in a hospital ward. Pediatr Pulmonol 21 (1996) 90-100
10. Panagea S., Winstanley C., Walshaw M.J., Ledson M.J., and Hart C.A. Environmental contamination with an epidemic strain of Pseudomonas aeruginosa in a Liverpool cystic fibrosis centre, and study of its survival on dry surfaces. J Hosp Infect 59 (2005) 102-107